A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer
Clinical trial NCT06029036 · UNKNOWN
Trial details
- NCT number
- NCT06029036
- Sponsor
- Peking University First Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-05
- Primary completion
- 2025-07-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.